Login

Elias Papatheodorou, CEO of Genkyotex, tells us more about his relationship with the BioDiscovery team 00:00:00

Share On Facebook Share On Twitter

BioDiscovery by Elias Papatheodorou, CEO of Genkyotex

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
James Clifton, CEO of The MISSION Group, discusses company insights in an executive interview with Mirriad Advertising.
00:10:00
Revolutionary Solar Tracking Technology Sparks Market Expansion via Strategic IPO | Louis Maurice, CEO, Groupe Okwind SA.
00:10:00
Banking on Emissions Reduction and Green Investment | Prince Maximillian of Liechtenstein , CEO , LGT Group.
00:10:00
Leading with Optimism and a Vision for Global Impact | Roberto Funari, CEO , Alpargatas SA.
00:10:00
Dundee's Arsenic Stabilization: Converting Toxic Waste into Safe, Long-Lasting Glass
00:00:00
Dr. Donna Skerrett, CEO, Paradigm Biopharmaceuticals Ltd
00:10:00
Supriya Lifescience MD Satish Wagh and Director Saloni Wagh on Q1 Results, Profits, and Future Expansion | Satish Wagh, Chairman, Supriya Lifescience Limited.
00:10:00
Power Minerals Explores High-Potential Lithium and Nickel-Cobalt Projects with Optimistic Drilling Results
00:10:00
long-time early-stage investor currently investing out of their 12th Fund which worth$800M.|Stephen Bloch,General Partner,Canaan Partners
00:10:00
Navigating Biotech Leadership: Insights, Risks, and Personal Growth from an Industry Veteran | Marc de Garidel, CEO, Abivax SA.
00:10:00
focus on proving all of the on-ramps that founders need from the early days|Alan Poensgen,Partner,Antler
00:10:00
"Navigating Q1FY25 Challenges and Opportunities: Hiren Ved's Analysis of Market Trends, Capital Expenditure, and Economic Momentum"

© 2017 - Neuhu+